- Home
- PTGX vs HOMB Comparison
PTGX vs HOMB Comparison
Compare PTGX & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | HOMB |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 6.0B |
| IPO Year | 2016 | 2006 |
Fundamental Metrics
Financial Performance| Metric | PTGX | HOMB |
|---|---|---|
| Price | $82.25 | $28.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | ★ $99.20 | $32.60 |
| AVG Volume (30 Days) | 600.9K | ★ 1.1M |
| Earning Date | 01-01-0001 | 04-14-2026 |
| Dividend Yield | N/A | ★ 2.88% |
| EPS Growth | ★ 404.32 | 3.61 |
| EPS | N/A | ★ 1.80 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.84 |
| Revenue Next Year | $501.99 | $5.14 |
| P/E Ratio | ★ N/A | $16.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.70 | $24.23 |
| 52 Week High | $96.54 | $30.83 |
Technical Indicators
Market Signals| Indicator | PTGX | HOMB |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 45.35 |
| Support Level | $80.40 | $29.02 |
| Resistance Level | $83.40 | $29.92 |
| Average True Range (ATR) | 3.21 | 0.63 |
| MACD | 0.04 | -0.12 |
| Stochastic Oscillator | 45.85 | 12.33 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About HOMB Home BancShares Inc.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.